NDC 24470-964-01 - LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24470-964
- Requested NDC
- 24470-964-01
- Package NDCs from labels
- 24470-964-01, 24470-964-20
- Manufacturer
- Cintex Services, LLC
- Effective date
- 2024-09-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE - Cintex Services, LLC | Cintex Services, LLC | 2024-09-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24470-964-01 | LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE | 7 g in 1 TUBE | GEL | 7 | 2 | |
| 24470-964-20 | LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE | 20 in 1 KIT | GEL | 20 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 24470-964-20 | EA - Each | 24470-964 | 8202a0fb-1009-4b94-844b-010e82d2629c | 1 | 2024-10-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | fecd1797-7757-4da8-b3a1-24b258634243 | 2022-10-12 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | 8ae0656c-36fb-48fb-886b-1031d11da552 | 2022-10-12 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | deec52c7-ebcf-422e-beab-bc1df2fe30cb | 2022-10-12 | Warnings, Adverse reactions | V13007Z41A |
| Lidotran | LIDOCAINE HYDROCHLORIDE | PureTek Corporation | cf715e54-c413-1e8f-e053-2995a90a076d | 2022-09-19 | Warnings, Adverse reactions | V13007Z41A |
| Lidothol | LIDOCAINE HCL, MENTHOL | Asclemed USA, Inc. | 6d7adaca-67dd-4a4b-a85c-d1c2a568dee2 | 2022-09-09 | Warnings, Adverse reactions | V13007Z41A |
| hydrocortisone acetate pramoxine HCl | HYDROCORTISONE ACETATE, PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 982f0862-2be8-4a65-8b61-8f3a95ab5951 | 2022-05-31 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate Pramoxine Hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 87a4c494-56f9-48f6-8592-d610c507a4fc | 2022-05-31 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | Padagis US LLC | 2fdb9940-6da8-49b0-a236-9817943f7a4b | 2022-05-31 | Adverse reactions | 3X7931PO74 |
| hydrocortisone acetate pramoxine hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 9eea5875-d153-4bba-aee2-b1d1cd8b5e57 | 2022-05-31 | Adverse reactions | 3X7931PO74 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Novitium Pharma LLC | ffb2d794-2c88-48a2-beff-d01b6fcea51f | 2022-03-25 | Warnings, Adverse reactions | V13007Z41A |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | APNAR PHARMA LP | cb60f2a6-8bab-c0f9-e053-2a95a90a422a | 2022-03-16 | Adverse reactions | 3X7931PO74 |
| Lydexa 4.12% | LIDOCAINE HYDROCHLORIDE | PureTek Corporation | aa1c9d39-1283-8c6b-e053-2a95a90af5b5 | 2022-03-02 | Warnings, Adverse reactions | V13007Z41A |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | Patrin Pharma Inc. | 7c1d2c8c-26e2-432f-b983-505f259665a9 | 2021-12-22 | Adverse reactions | 3X7931PO74 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | International Medication Systems, Limited | 2c48cfac-81eb-4a81-8590-bc94574dd4c3 | 2021-12-14 | Warnings, Adverse reactions | V13007Z41A |
| Bactine Max | BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE | WellSpring Pharmaceutical Corporation | 28e8a311-20a4-45a1-8d5d-ca42b101c275 | 2021-02-24 | Warnings | V13007Z41A |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | 6702589d-6a15-40fe-877a-a9a1a4ad0f7a | 2020-11-30 | Warnings, Adverse reactions | V13007Z41A |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | Proficient Rx LP | 43ed7a9a-0aaf-4987-8367-e2490d1b8448 | 2020-05-07 | Adverse reactions | 3X7931PO74 |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Proficient Rx LP | 5b4b36dd-da60-47de-a2c1-517a52ab3549 | 2020-05-01 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | b8803e38-fe30-48ec-9399-013f2880e0eb | 2020-04-09 | Warnings, Adverse reactions | V13007Z41A |
| DermacinRx Lidotral | LIDOCAINE HYDROCHLORIDE | PureTek Corporation | 23efec58-67cc-418d-85f5-7ef156443cbf | 2019-02-04 | Warnings, Adverse reactions | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.